Join us for a seminar to hear about the ethics and governance of dual-use and gain-of-function research and the practical challenges of biorisk management. The seminar will provide ample opportunity for discussion and sharing of experiences.

Date and Time

Mon, 11 November 2019

4:30 PM – 6:30 PM


10 Medical Drive

CRC Auditorium, MD11

Singapore, 117597

View Map

Registration: Click HERE to register.



• Researchers in Biology and Biomedicine

• Biosafety Managers

• Those involved in Biorisk Management

• Lab Managers

• Public Health Researchers

• Policymakers

• IRB Members


Professor Michael Selgelid is Director of the Monash Bioethics Centre at Monash University and Adjunct Professor in the School of Public Health and Preventative Medicine at Monash University. He is an internally-recognized expert on the ethics of dual-use research and public health ethics (especially regarding infectious disease). In 2015 Michael was commissioned by the US NIH to produce a White Paper on ethical issues associated with gain-of-function research. He co-authored Ethical and Philosophical Consideration of the Dual-Use Dilemma in the Biological Sciences (Springer 2008) and co-edited On The Dual Uses of Science and Ethics: Principles, Practices, and Prospects (ANU Press 2013), Ethics and Security Aspects of Infectious Disease Control: Interdisciplinary Perspectives (Ashgate 2012), Infectious Disease Ethics (Springer 2011), and Ethics and Infectious Disease (Blackwell 2006).

Dr Bintou Ahidjo is a senior research fellow of the NUS Department of Microbiology and Immunology and the Head of the Imaging and TB team of the NUSMed BSL-3 Core Facility with over a decade’s experience working within BSL-3 laboratories around the world. Prior to her current appointment, Dr Ahidjo completed a post-doctoral fellowship with Dr William Bishai at the Johns Hopkins University Center for Tuberculosis Research (USA) following which she established a clinical research BSL-3 diagnostic laboratory in South Africa. She recently established a PET-CT imaging suite within the NUSMed BSL-3 Core Facility – the first such facility in Asia to image risk group 3 pathogens. Her current interest lies with in vivo imaging of risk group 3 infectious diseases with a particular focus on tuberculosis. She is also an elected member of the Biorisk Association of Singapore which is a not-for-profit organization that aims, amongst others, to provide a key platform for knowledge-sharing as well as promotion of biorisk management as an independent discipline.


This event is co-sponsored by the initiative for Science, Health, and Policy-Relevant Ethics (SHAPES) at the Centre for Biomedical Ethics, NUS, and the Biorisk Association of Singapore (BAS).

Disclaimer: NUS will use your business contact data for administration purposes only pertaining to this and future events that we may organize. NUS will not provide third parties with any of your business contact data or use it for any other purpose unless we are required to by law. By registering for this event, you consent to the collection and storage of your data. If you wish to amend your business contact data kept by NUS or withdraw your consent, please contact Muhammad Ali at +65-66015173 or and we will respond to you within 3 working days.